December 6, 2022
UNC Lineberger researchers and colleagues will be presenting the latest findings from basic, translational and clinical studies at the 45th annual San Antonio Breast Cancer Symposium.
November 14, 2022
A genomic study of more than 200 people with the most common type of bladder cancer that has spread could help guide how the cancer would respond to immunotherapy.
September 27, 2022
Adding detection of immune cell protein SYNGR3 to current protocols could lead to a more reliable way of determining which patients with head and neck cancer need less intensive treatment.
September 26, 2022
The NCI awarded $9.3 million in support of two five-year research projects from researchers in the UNC Lineberger Pancreatic Cancer Center of Excellence in partnership with other institutions.
September 22, 2022
Using the wrong mathematical formula to assess heartbeat rhythms may lead oncologists to inappropriately stop life-saving chemotherapy, according to research findings from UNC Lineberger scientists.
July 22, 2022
The UNC RNA Discovery Center, led by Chad Pecot, MD, will cultivate an inclusive community of scientists dedicated to investigating all aspects of RNA biology.
June 26, 2022
Sascha Tuchman, MD, MHS, specializes in hematology, and specifically multiple myeloma and amyloidosis. At UNC Lineberger, he collaborates with other UNC Lineberger clinicians and scientists, and works to cultivate the next generation of myeloma experts.
May 16, 2022
Victoria Bae-Jump, MD, PhD, has been elected co-chair of the National Cancer Institute Gynecologic Cancers Steering Committee’s Uterine Task Force.
May 13, 2022
We’re proud to announce Ashwin Somasundaram, MD, as the newest member of the UNC Lineberger Pancreatic Cancer Center of Excellence (PCCE).
April 26, 2022
A newer, less expensive nanotechnology may make it possible to more accurately diagnose children with acute leukemia in lower income countries, according to findings by Thomas Alexander, MD, MPH, and colleagues.
